Press Releases

Intensity Therapeutics, Inc. Announces Presentation on INT230-6 Clinical Study at the 2018 ASCO conference.

May 18 2018

Intensity Therapeutics, Inc., a privately held biotechnology company developing proprietary immune cell-activating cancer treatments, today announced that an abstract highlighting progress in the INT230-6 clinical development program will be presented as a poster at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting taking place June 1-5 in Chicago. “The abstract being presented at… Read more »

Mark A. Goldberg, MD, Joins Intensity Therapeutics, Inc. Board of Directors

May 18 2018

Intensity Therapeutics, Inc., a privately held biotechnology company developing proprietary cancer immune-based drug products for direct intratumoral injection, today announced that Mark A. Goldberg, MD has been appointed to the Company’s Board of Directors effective May 1, 2018. Dr. Mark A. Goldberg recently served as president and COO of PAREXEL International, one of the world’s… Read more »

Intensity Therapeutics, Inc. Reports Positive Safety Data from On-going IT-01 Phase 1/2 Trial

Feb 18 2018

Intensity Therapeutics, Inc., a privately held biotechnology company developing proprietary cancer immune-based drug products for direct intratumoral injection, today announced completion of the first safety cohort (A) of the Company’s Phase 1/2 international clinical study evaluating lead product, INT230-6. Following intratumoral drug injections into superficial lesions in six patients with either ovarian, thyroid, head and… Read more »

View All Press Releases

Publications/Papers/Posters

ASCO 2018 Poster Presentation TPS2609

Phase 1/2 trial evaluating intratumoral administration of INT230-6 alone and in combination with an anti-PD1 antibody for advanced malignancies. TPS2609

AACR 2017 Poster

Tumor cell death caused by INT230-6 induces protective T cell immunity.

SITC 2016 Poster

Intratumoral injection of INT230-6 induces protective T cell immunity.

View All Publications/Papers/Posters